esv3826894
- Organism: Homo sapiens
- Study:estd219 (1000 Genomes Consortium Phase 3 Integrated SV)
- Variant Type:copy number variation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:54,964
- Publication(s):1000 Genomes Consortium Phase 3 Integrated SV
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 225 SVs from 39 studies. See in: genome view
Overlapping variant regions from other studies: 225 SVs from 39 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
esv3826894 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000002.12 | Chr2 | 161,715,902 (-500, +0) | 161,770,865 (-0, +500) |
esv3826894 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000002.11 | Chr2 | 162,572,412 (-500, +0) | 162,627,375 (-0, +500) |
Variant Call Information
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
essv17946392 | Remapped | Perfect | NC_000002.12:g.(16 1715402_161715902) _(161770865_161771 365)del | GRCh38.p12 | First Pass | NC_000002.12 | Chr2 | 161,715,902 (-500, +0) | 161,770,865 (-0, +500) |
essv17946392 | Submitted genomic | NC_000002.11:g.(16 2571912_162572412) _(162627375_162627 875)del | GRCh37 (hg19) | NC_000002.11 | Chr2 | 162,572,412 (-500, +0) | 162,627,375 (-0, +500) |